Introduction: The effect of plant sterols (PS) on oxidative stress in subjects with obesity is uncharacterized, and evidence in non-obese subjects is heterogeneous. In hypercholesterolemic subjects, PS reduced 8-isoprostane and oxidized LDL, whereas other similar studies in the same population reported no significant changes. Methodology: Randomized, double-blind, placebo-controlled crossover trial (NCT06481020) in subjects with overweight or class I–III obesity and mild hypercholesterolemia (BMI: 36.4 ± 4.2 kg/m²; LDL > 115 mg/dL; n=23). Participants received 2 g/day PS or placebo for 8 weeks (6-week washout). Reduced and oxidized glutathione, ophthalmic acid, S-adenosylhomocysteine, S-adenosylmethionine, 3-nitrotyrosine, o-tyrosine, p-tyrosine, 8-hydroxy-2′-deoxyguanosine, malondialdehyde, 8-isoprostane, oxidized LDL, and cholesterol oxidation products (COPs), absolute and cholesterol-normalized, were quantified in serum before and after each treatment. Results and Discussion: Oxidized glutathione was undetectable in most participants (below the detection limit, 4.9 ng/mL, in >50%) and excluded. PS did not significantly affect any measured biomarker except the following. Ophthalmic acid increased versus baseline in both periods (placebo: +27.7%, p=0.006; PS: +26.6%, p=0.020), without between-group difference (p=0.857). S-adenosylhomocysteine decreased only after PS (−15.5%, p=0.023) despite unchanged S-adenosylmethionine, possibly reflecting a modest improvement in methylation potential, though the relevance of this isolated change remains uncertain. The cholesterol-normalized ratios of four COPs significantly decreased after PS: 7α-hydroxycholesterol (−1.8%, p=0.040), 5α,6α-epoxycholesterol (−2.3%, p=0.008), 5β,6β-epoxycholesterol (−2.4%, p=0.030), and cholestane-3β,5α,6β-triol (−2.6%, p=0.004). These ratio reductions, but not in absolute concentrations, indicate an active antioxidant effect rather than a passive consequence of cholesterol lowering, which would otherwise have reduced absolute COPs in parallel. Conclusions: PS may exert a mild but specific antioxidant effect on cholesterol oxidation in subjects with obesity, independently of cholesterol lowering. Although COPs are biologically relevant oxidative species, the reduction was small and its clinical significance is uncertain. Larger trials are needed to confirm these findings.